The Global Market for Immunochemicals (Research Antibodies) is Projected to Reach US$5.1 Billion by 2024

Rising Government Funding and Increasing R&D Initiatives Drive the Global Immunochemicals Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global Immunochemicals market. The global market for Immunochemicals (Research Antibodies) is projected to reach US$5.1 billion by 2024, driven by increasing R&D initiatives in the life sciences sector, rising government funding for proteomics research and drug discovery and growing collaborations between academic institutes and industries.

The global market for immunochemicals for research is set to witness rapid growth, driven by increasing R&D initiatives in the life sciences sector, rising government funding for proteomics research and drug discovery, and increasing collaborations between academic institutes and industries. Antibodies constitute critical constituents of numerous research methodologies, including protein and antibody micro arrays, cell-based immunoassays, and protein electrophoresis. Significant growth opportunities are also available for detecting antibody interactions, particularly for chemiluminescent, fluorescent, and radioactive probes. Further, antibodies are also used extensively for drug delivery, imaging, therapeutics, and diagnostics, as well as finding application as assay components, and research tools. The critical role of antibodies in the field of drug discovery and research is attributed to their vast diversity, as well as their ability to exhibit high specificity in antibody-antigen interactions. Such characteristics are highly beneficial in unraveling details of various biological systems. The high significance of antibodies is primarily attributed to their ability to identify and isolate proteins, which holds enormous importance in the field of proteomics.
Continuous rise in the number of suppliers as well as the availability of a broad range of antibodies has been favoring growth in the catalogue antibody market. However, the scenario is changing with the advent of proteomics and the identification of newer targets, which in turn is fostering the demand for custom antibodies. Genome projects and proteome research are creating growth opportunities for custom antibodies by facilitating discovery of novel proteins, thereby encouraging manufacturers to augment and revamp their stocks with novel antibodies. The preference for custom antibodies continues to grow, despite their higher price in comparison to catalogue antibodies.
Rising number of cancer cases is leading to rising demand for cancer research, in turn driving the cancer research antibodies market. Key cancer research areas include metastasis, apoptosis, autophagy, tumor suppressors, metabolism, proliferative signaling, inflammation, among others. Research antibodies are increasingly being used as tools in several applications, such as measuring enzymes activity, profiling proteins, signaling pathways, identifying candidate biomarkers, and measuring the expression levels or modifications of cancer-related proteins.

As stated by the new market research report on Immunochemicals, the U.S. represents the largest market worldwide, backed by the increase in NIH funding. Asia-Pacific ranks as the fastest growing market worldwide with a CAGR of 13.9% through the analysis period. China is expected to spearhead growth in the region supported by the increased investments in research and development. Active government support for biotechnology research and emergence of India and China as major centers of clinical research are also favoring the growth of immunochemicals market in the region.

Major players in the market include Abcam Plc., Agilent Research Laboratories, Beckman Coulter GmbH, Biolegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., GenScript Biotech Corporation, PerkinElmer Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Merck (Sigma-Aldrich Corporation), and Thermo Fisher Scientific Inc., among others..

The research report titled “Immunochemicals: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections in value terms for all major geographic markets such as United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), Latin America and Rest of World. Segments analyzed include Catalog Antibodies and Custom Antibodies.


Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.

Comments

Popular posts from this blog

The Global Market for Surfing is Projected to Reach US$9.5 Billion by 2022

The Global Market for Private Tutoring Services is Forecast to Reach US$227 Billion by 2022